Cantharis 30c (BrandStorm HBC)


Welcome to the PulseAid listing for the Cantharis 30c drug offered from BrandStorm HBC. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.




LABELER NAME / MANUFACTURER: BrandStorm HBC
NON-PROPRIETARY NAME: LYTTA VESICATORIA
SUBSTANCE NAME: LYTTA VESICATORIA
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: SUBLINGUAL
DOSAGE FORM: PELLET
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2011-11-22
END MARKETING DATE: 2019-07-21


Cantharis 30c HUMAN OTC DRUG Details:

Item DescriptionCantharis 30c from BrandStorm HBC
LABELER NAME: BrandStorm HBC
DEA SCHEDULE:
ACTIVE STRENGTH: 30([hp_C]/1)
START MARKETING DATE: 2011-11-22
END MARKETING DATE: 2019-07-21
PRODUCT ID: 76472-1138_8df79f54-0a60-4e2b-8c44-171e37e6970b
PRODUCT NDC: 76472-1138
APPLICATION NUMBER:

Other LYTTA VESICATORIA Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BrandStorm HBCCantharis 30c
HOMEOLAB USA INCCANTHARIS
Hyland’sCANTHARIS
Laboratoires BoironCantharis
Natural Health SupplyBladder Irritation
Paramesh Banerji Life Sciences LLCCantharis 200C
Rxhomeo Private Limited d.b.a. Rxhomeo, IncCANTHARIS
Seroyal USACANTHARIS
STANDARD HOMEOPATHIC COMPANYCANTHARIS
Washington Homeopathic ProductsCantharis